Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-016-1199-2
PubMed Identifier: 26842107
Publication URI: http://europepmc.org/abstract/MED/26842107
Type: Journal Article/Review
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215